Picture of IRLAB Therapeutics AB logo

IRLAB A — IRLAB Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: IRLAB Extends, Expands Debt Financing

Feb 18 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * DURATION OF EXISTING LOAN FROM FENJA CAPITAL OF SEK 55 MLN
HAS
BEEN EXTENDED FROM MAY 22, 2025, TO JUNE 30, 2026, AT LATEST
    * LOAN CAN BE EXTENDED BY EXTRA SEK 20 MLN UNDER CERTAIN
CONDITIONS
    * HAS RAISED NEW LOANS FROM SOME OF ITS MAJOR SHAREHOLDERS
FOR
TOTAL OF SEK 22.4 MLN

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFNT5FTK
 Further company coverage:  IRLABa.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on IRLAB Therapeutics AB

See all news